ATE390918T1 - Salze der (r)-2-(3-benzoylphenyl)propionsäure und pharmazeutische präparate, die sie enthalten - Google Patents

Salze der (r)-2-(3-benzoylphenyl)propionsäure und pharmazeutische präparate, die sie enthalten

Info

Publication number
ATE390918T1
ATE390918T1 AT99101322T AT99101322T ATE390918T1 AT E390918 T1 ATE390918 T1 AT E390918T1 AT 99101322 T AT99101322 T AT 99101322T AT 99101322 T AT99101322 T AT 99101322T AT E390918 T1 ATE390918 T1 AT E390918T1
Authority
AT
Austria
Prior art keywords
salts
pharmaceutical preparations
preparations containing
benzoylphenyl
propionic acid
Prior art date
Application number
AT99101322T
Other languages
English (en)
Inventor
Riccardo Bertini
Cinzia Bizzarri
Laura Brandolini
Gabriella Melillo
Gianfranco Caselli
Gaetano Clavenna
Original Assignee
Dompe Pha R Ma Spa Res & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Pha R Ma Spa Res & Mfg filed Critical Dompe Pha R Ma Spa Res & Mfg
Application granted granted Critical
Publication of ATE390918T1 publication Critical patent/ATE390918T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99101322T 1998-01-28 1999-01-25 Salze der (r)-2-(3-benzoylphenyl)propionsäure und pharmazeutische präparate, die sie enthalten ATE390918T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI000146A IT1298214B1 (it) 1998-01-28 1998-01-28 Sali dell'acido (r) 2-(3-benzoilfenil) propionico e loro composizioni farmaceutiche.

Publications (1)

Publication Number Publication Date
ATE390918T1 true ATE390918T1 (de) 2008-04-15

Family

ID=11378720

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99101322T ATE390918T1 (de) 1998-01-28 1999-01-25 Salze der (r)-2-(3-benzoylphenyl)propionsäure und pharmazeutische präparate, die sie enthalten

Country Status (10)

Country Link
US (1) US6069172A (de)
EP (1) EP0935961B1 (de)
AT (1) ATE390918T1 (de)
CY (1) CY1108168T1 (de)
DE (1) DE69938440T2 (de)
DK (1) DK0935961T3 (de)
ES (1) ES2304798T3 (de)
IT (1) IT1298214B1 (de)
PT (1) PT935961E (de)
SI (1) SI0935961T1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
WO1999052528A1 (en) * 1998-04-11 1999-10-21 Errekappa Euroterapici S.P.A. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
ES2281981T3 (es) 1998-09-03 2007-10-01 Loma Linda University Medical Center Composicion farmaceutica y uso de aines para tratar la inflamacion.
EP1031347B1 (de) 1999-01-27 2002-04-17 Idea Ag Transnasaler Transport bzw. Impfung mit hochadaptierbaren Trägern
EP1031346B1 (de) 1999-01-27 2002-05-02 Idea Ag Nichtinvasive Impfung durch die Haut
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US7056531B1 (en) * 2000-05-04 2006-06-06 Nature's Way Products, Inc. Sustained release compositions for orally administered substances and methods
DE10032537A1 (de) * 2000-07-05 2002-01-31 Labtec Gmbh Dermales System, enthaltend 2-(3-Benzophenyl)Propionsäure
AU2001292929A1 (en) 2000-09-26 2002-04-08 Temple University Of The Commonwealth System Of Higher Education Analgesic and glucosamine compositions
ITMI20010395A1 (it) * 2001-02-27 2002-08-27 Dompe Spa Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate
JP2002265365A (ja) * 2001-03-08 2002-09-18 Koyo Chemical Kk 好中球機能抑制剤
US6995190B2 (en) * 2001-03-09 2006-02-07 Veterinary Solutions Method and treatment with ketoprofen solution
ITMI20012434A1 (it) 2001-11-20 2003-05-20 Dompe Spa Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
EP1603548A4 (de) * 2003-02-05 2007-10-10 Myriad Genetics Inc Verfahren und zusammensetzung zur behandlung neurodegenerativer erkrankungen
EP1457485A1 (de) * 2003-03-14 2004-09-15 Dompé S.P.A. Sulfonsäuren, deren Derivate sowie sie enthaltenden pharmazeutischen Zubereitungen
WO2005065069A2 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2584475A1 (en) * 2004-11-12 2006-05-18 Idea Ag Extended surface aggregates in the treatment of skin conditions
US20060147481A1 (en) * 2005-01-03 2006-07-06 Michael Strobel Ketoprofen powder for oral use
EP1739078A1 (de) 2005-05-30 2007-01-03 Jerini AG C5a-Rezeptor-Antagonisten
CA2615063A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
CN100460413C (zh) * 2006-01-16 2009-02-11 中国药科大学 羧酸类非甾体抗炎药与氨基葡萄糖或其盐合成的化合物及其合成方法和应用
WO2007142707A1 (en) * 2006-02-06 2007-12-13 Pharmaceutical Solutions, Inc. Non-steroidal anti-inflammatory oral powder and liquid preparations for administration to animals
CN101084898B (zh) * 2006-06-06 2011-03-16 朱志宏 一种镇咳祛痰的复方化学药及其制备工艺
EP2046119A2 (de) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Behandlung von psychiatrischen störungen
EP2166006A1 (de) 2008-09-18 2010-03-24 Dompe' S.P.A. 2-Arylpropionsäuren und -Derivate und pharmazeutische Zusammensetzungen, die diese enthalten
EP2671569B1 (de) 2012-06-06 2015-09-16 Galenicum Health S.L. Stabile pharmazeutische Zusammensetzungen mit schnell einsetzender Wirkung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840856A (en) * 1991-03-29 1998-11-24 Genentech, Inc. Antibodies to a human PF4 superfamily receptor
FR2687915B1 (fr) * 1992-02-28 1995-05-05 Rhone Poulenc Rorer Sa Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r).
US5331000A (en) * 1992-03-09 1994-07-19 Sepracor Inc. Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
WO1994020449A1 (en) * 1993-03-09 1994-09-15 Dompe'farmaceutici Spa Salts of 2-(3-benzoylphenyl)propionic acid with achiral and chiral organic bases and pharmaceutical compositions thereof
US6160018A (en) * 1995-03-13 2000-12-12 Loma Linda University Medical Center Prophylactic composition and method for alzheimer's Disease
IT1277741B1 (it) * 1995-12-28 1997-11-12 Dompe Spa Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici

Also Published As

Publication number Publication date
DK0935961T3 (da) 2008-07-28
DE69938440D1 (de) 2008-05-15
CY1108168T1 (el) 2014-02-12
ES2304798T3 (es) 2008-10-16
SI0935961T1 (sl) 2008-10-31
US6069172A (en) 2000-05-30
DE69938440T2 (de) 2009-05-07
EP0935961A3 (de) 2000-08-23
PT935961E (pt) 2008-07-11
IT1298214B1 (it) 1999-12-20
EP0935961A2 (de) 1999-08-18
ITMI980146A1 (it) 1999-07-28
EP0935961B1 (de) 2008-04-02

Similar Documents

Publication Publication Date Title
DE69938440D1 (de) Salze der (R)-2-(3-Benzoylphenyl)propionsäure und pharmazeutische Präparate, die sie enthalten
AU583991B2 (en) Hypoglycemic thiazolidinediones
ES2152485T3 (es) Procedimiento para preparar comprimidos que contienen amoxicilina y clavulanato recubiertos de una pelicula polimerica acuosa.
DE69206345D1 (de) Arzneimittel zur intranasalen Verabreichung, die Ketorolac R enthalten.
IT8619004A0 (it) Sali idrosulubili di composti adattivita&#39; antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
ES2058024A1 (es) Nuevo derivado arilpropionico, procedimiento de fabricacion del mismo y su utilizacion como analgesico.
MA23608A1 (fr) Forme de dosage ii d&#39;unite multiple en comprime
ATE75604T1 (de) Antiphlogistika enthaltende pharmazeutische formulierungen mit gesteuerter freigabe.
ES2145264T3 (es) (2,4-disulfofenil)-n-tert-butilnitrona, sus sales y su utilizacion como agentes captadores de radicales farmaceuticos.
MA23170A1 (fr) Procede de preparation d&#39;un nouveau compose .
IS1564B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
BRPI9811989B8 (pt) uso do ácido 9-cis retinóico para a fabricação de um medicamento
MX9307779A (es) Compuestos benzoicos fundidos.
ES2033682T3 (es) Procedimiento para preparar una composicion farmaceutica que contiene acido 2-(2-fluoro-4-bifenilil)propionico o una de sus sales.
ATE325611T1 (de) Borsäuresalze und deren verwendung in der bereitstellung von medikamente für die thrombosebehandlung
GR3022742T3 (en) New derivatives of non-steroidal anti-inflammatory, analgesic and/or antipyretic substances, their use and pharmaceutical formulations containing them
DE69736140D1 (de) Pharmazeutische injizierbare Lösungen, die Paracetamol und Kombinationen aus Paracetamol mit anderen Aktivsubstanzen enthalten
DE3881073D1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
NO308579B1 (no) Anvendelse av aromatiske karboksylsyrederivater til fremstilling av farmasøytiske preparater for terapi og profylakse av lys- og aldersbetingede hudskader, og for Õ fremme sÕrhelbredelse, samt nye forbindelser
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
DE68919378D1 (de) Thienotriazolodiazepine und ihre pharmazeutische Verwendung.
GEP19991871B (en) Thiol Derivatives with Metallopeptidase Inhibitory Activity
PT81786B (pt) Processo para a preparacao de inibidores da dopamina-beta-hidroxilase
DK0627916T3 (da) Farmaceutisk præparat, anvendeligt som analgetikum og indeholdende (R)-2-(3-benzoylphenyl)propionsyre
BR9400020A (pt) Composto, processo para sua preparação, composicões farmacêuticas e uso

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0935961

Country of ref document: EP